Added to YB: 2026-03-02
Pitch date: 2026-02-13
PME.AX [neutral]
Pro Medicus Limited
+10.19%
current return
Author Info
No bio for this author
Company Info
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe.
Market Cap
AUD 12.1B
Pitch Price
AUD 117.97
Price Target
N/A
Dividend
0.55%
EV/EBITDA
66.36
P/E
51.83
EV/Sales
49.56
Sector
Health Care Technology
Category
growth
Pro Medicus (ASX: PME) H1 FY 2026 Results Cause Share Price Plunge
PME.AX (earnings): H1 FY26 rev $124.8M (+28.4% YoY), underlying NPAT $90.7M (+29.7%), but slowest HoH growth since H1 FY24. US rev growth slowed to 8% (lowest since COVID). Share price -24% to $129 on AI fears re: transactional model. Mgmt argues Visage remains critical workflow tool for radiologists; AI tools partner via platform vs replace. At ~90x FY26 PE (conservative $140M NPAT est), valuation compelling if profit doubles in 5yr via market share gains. Cautiously bullish long-term but expect near-term pressure as software pessimism peaks.
Read full article (6 min)